Researchers use new tool to counter multiple myeloma drug resistance

September 9, 2011 in Cancer

Moffitt Cancer Center researchers, and colleagues, are pioneering promising research utilizing a monitoring technology that could provide a better understanding of acquired drug resistance and assist in clinical decision-making for developing individualized patient treatments for multiple myeloma.

"Acquired " (ADR) is a major problem encountered in treating some forms of cancer. The ability to monitor the proteins involved in drug resistance has been a hurdle facing cancer researchers. However, a team of researchers at Moffitt , and colleagues, are pioneering promising research utilizing a that could provide a better understanding of ADR and assist in clinical decision-making for developing individualized patient treatments for . The technique has potentially broader applications to other as well.

Their research results are published in the October issue of Molecular and Cellular Proteomics.

"Multiple myeloma is an incurable malignancy in the bone marrow," said John M. Koomen, Ph.D., assistant member in Molecular Oncology and and scientific director of Moffitt's Proteomics Core Facility. "While patients with multiple myeloma initially respond to chemotherapy, they eventually develop drug resistance from a variety of factors. We want to be able to detect acquired drug resistance, so that we can change the therapeutic regimen to meet the needs of the patient."

The research team has employed a method called Multiple Reaction Monitoring (LC-MRM) to monitor proteins determined to be involved in acquired drug resistance. This was based on the prior myeloma research conducted at Moffitt by William S. Dalton, Ph.D., M.D., Moffitt's CEO and center director, and colleagues.

Among the factors in ADR is an alteration in the "apoptopic machinery" of cells. Apoptosis, or programmed , is determined by the interaction of anti-apoptosis and pro-apoptosis proteins in response to both external and internal stimuli. This interaction is known to play a role in ADR.

"Being able to monitor proteins is a major step in understanding multiple myeloma biology and its biomarkers to assist in clinical decision-making and developing personalized cancer therapy," explained Koomen, the study's corresponding author.

LC-MRM has been successfully used to quantify biomarkers of human disease by comparing protein expressions of patients with disease and disease-free controls. LC-MRM has also been used to monitor the signaling pathways and networks in cells. In the method developed by the Moffitt researchers, protein separation techniques are coupled with LC-MRM to quantify selected target proteins.

In their search for apoptosis-regulating signals, the researchers used LC-MRM to quantify the expression levels of proteins in drug-resistant cells vs. non-drug-resistant cells.

Moffitt's "Quantitative Assay Database," or QuAD, used to share methods and reagents for the study of cancer biology, also supported these experiments. QuAD enables the quantitative assessment of the protein components in cell-signaling pathways and biological processes and holds promise for the systematic investigation of treatment responses in cancer. QuAD is also employed for managing data related to the BRAF gene, which is studied due to its relevance to melanoma, and numerous other genes related to cancer.

"The potential for LC-MRM to assist treatments across diseases is enormous," concluded Koomen. The technology provides new ways to evaluate cancer that can be applied to research and clinical practice.

Provided by H. Lee Moffitt Cancer Center & Research Institute

5 /5 (2 votes)  

Rank 5 /5 (2 votes)
Relevant PhysicsForums posts
  • A question about drug tolerance
    createdMay 23, 2012
  • Poor nutrition leading to overeating?
    createdMay 23, 2012
  • Math and dyslexia?
    createdMay 21, 2012
  • portable metabolism meter?
    createdMay 21, 2012
  • Rare medical conditions on 20/20 tonight
    createdMay 18, 2012
  • "Good" Cholesterol in Doubt
    createdMay 17, 2012
  • More from Physics Forums - Medical Sciences

More news stories

Skp2 activates cancer-promoting, glucose-processing Akt

HER2 and its epidermal growth factor receptor cousins mobilize a specialized protein to activate a major player in cancer development and sugar metabolism, scientists report in the May 25 issue of Cell.

Cancer created 16 hours ago | popularity not rated yet | comments 0 | with audio podcast

Pancreatectomy OK without downstaging from therapy

(HealthDay) -- Pancreatectomy improves median survival in pancreatic cancer patients even when presurgical neoadjuvant therapy does not lead to radiographic downstaging of tumors, according to a study published ...

Cancer created 17 hours ago | popularity not rated yet | comments 0

Common therapies for basal cell carcinoma offer similar survival

(HealthDay) -- For patients with superficial basal cell carcinoma (sBCC), treatment with imiquimod or photodynamic therapy (PDT) results in similar long-term tumor-free survival, according to a review published ...

Cancer created 17 hours ago | popularity not rated yet | comments 0

Cancer may require simpler genetic mutations than previously thought

Chromosomal deletions in DNA often involve just one of two gene copies inherited from either parent. But scientists haven't known how a deletion in one gene from one parent, called a "hemizygous" deletion, can contribute ...

Cancer created 20 hours ago | popularity not rated yet | comments 0 | with audio podcast

New prostate cancer screening guidelines face a tough sell, study suggests

(Medical Xpress) -- Recent recommendations from the U.S. Preventive Services Task Force (USPSTF) advising elimination of routine prostate-specific antigen (PSA) screening for prostate cancer in healthy men are likely to encounter ...

Cancer created 22 hours ago | popularity not rated yet | comments 1


Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse

(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...

Tongue analysis software uses ancient Chinese medicine to warn of disease

For 5,000 years, the Chinese have used a system of medicine based on the flow and balance of positive and negative energies in the body. In this system, the appearance of the tongue is one of the measures used to classify ...

Inherited DNA change explains overactive leukemia gene

A small inherited change in DNA is largely responsible for overactivating a gene linked to poor treatment response in people with acute leukemia.

Early physical therapist treatment associated with reduced risk of healthcare utilization and reduced overall healthcare

A new study published in Spine shows that early treatment by a physical therapist for low back pain (LBP), as compared to delayed treatment, was associated with reduced risk of subsequent healthcare utilization and lower ...

New device allows pacemaker patients to safely undergo MRIs

For many, it's a medical conundrum: The very pacemaker keeping their heart in rhythm prevents them from undergoing an MRI to diagnose other ailments, because interaction between the two devices could prove deadly.

First study to suggest that the immune system may protect against Alzheimer's changes in humans

Recent work in mice suggested that the immune system is involved in removing beta-amyloid, the main Alzheimer's-causing substance in the brain. Researchers have now shown for the first time that this may apply in humans.